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Osteoporosis, osteopenia, and atherosclerotic vascular
disease
Wilbert S. Aronow
Abstract
Older women with low bone mineral density (BMD) have a higher prevalence
of atherosclerotic vascular disease (coronary artery disease, ischemic stroke, or
peripheral arterial disease) than older women with normal BMD. Three coronary
angiographic studies have shown that low BMD is associated with obstructive
coronary artery disease. Low BMD has been shown to be associated with stress
test-induced myocardial ischemia, reduced exercise capacity, and with aortic
valve calcification. Women with osteoporosis have an increased risk for
cardiovascular events. Treatment of osteoporosis or osteopenia should include
therapeutic measures to prevent cardiovascular events.
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Introduction
According to the criteria of the World Health Organization, osteoporosis
is diagnosed when the bone mineral density (BMD) is greater than 2.5
standard deviations below peak bone mass and osteopenia is diagnosed
when the BMD is 1-2.5 standard deviations below peak bone mass [1]. This
review  article  will  discuss  the  relationship  between  low  BMD  and
atherosclerotic vascular disease.
Atherosclerotic vascular disease 
Dual energy X-ray absorptiometry (DEXA) scans were used to measure
BMD in a retrospective case comparison pilot study in 101 postmenopausal
women, mean age 76 years, in a nursing home affiliated with New York
Medical College [2]. The DEXA scans were obtained because the United
States Preventive Services Task Force and the National Osteoporosis
Foundation recommend measuring BMD at least once in all women older
than 65 years [3, 4]. BMD was measured in the hips and spine in all 
101 patients by DEXA scan obtained from a computerized radiology data  -
base. Of 101 patients, 51 (51%) had a low BMD [2]. 
The mean age and prevalence of smoking, hypertension, diabetes
mellitus, and hypercholesterolemia were not significantly different between
women with a low BMD and those with a normal BMD. However,
atherosclerotic vascular disease defined as symptomatic coronary artery
disease, cerebrovascular disease, or peripheral arterial disease was present
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in 31 of 51 women (61%) with osteoporosis or
osteopenia versus 19 of 38 women (38%) with
normal BMD (p < 0.025) [2]. Coronary artery disease
and cerebrovascular disease were diagnosed as
previously described [5-8]. 
A retrospective analysis was performed in 1000
post  menopausal women, mean age 68 years (range
51 to 97 years), seen consecutively at a general
medicine clinic at the University of Iowa School 
of Medicine to investigate the prevalence of athe  -
rosclerotic vascular disease in women with osteo  -
porosis, osteopenia, and no osteoporosis or osteo  -
penia  [9].  Women  were  diagnosed  as  having
osteoporosis or osteopenia according to the criteria
of the World Health Organization [1]. 
Of 1000 women, 154 (15%) had osteoporosis, 
179 (18%) had osteopenia, and 667 (67%) had no
osteoporosis or osteopenia [9]. The mean age and
prevalence of race, current cigarette smoking,
hypertension, diabetes mellitus, and hyper  cho  -
lesterolemia  were  not  significantly  different
between women with osteoporosis, osteopenia, and
no osteoporosis or osteopenia. Atherosclerotic
vascular disease was defined as the presence 
of coronary artery disease, ischemic stroke, or
peripheral arterial disease. Atherosclerotic vascular
disease occurred in 92 of 154 women (60%) with
osteoporosis, in 63 of 179 women (35%) with
osteopenia, and in 148 of 667 women (22%) with
no  osteoporosis  or  osteopenia.  P values  were 
< 0.001 comparing osteoporosis with osteopenia, 
< 0.001 comparing osteoporosis with no oste  o  -
porosis or osteopenia, and < 0.001 comparing
osteopenia with no osteoporosis or osteopenia [9].
In 31 936 Swedish twins followed up from age
50 years, the adjusted hazard ratio for hip fracture
was  significantly  increased  4.40  times  after
a diagnosis  of  heart  failure,  5.09  times  after
a diagnosis of stroke, 3.20 times after a diagnosis
of peripheral arterial disease, and 2.32 times after
a coronary event [10]. 
Coronary artery disease
In 5050 women and men aged 50 to 79 years,
self-reported myocardial infarction was insigni  -
ficantly increased by 22% in women with a low
BMD and was significantly increased (p = 0.03) by
39% in men with a low BMD [11]. In 45 post  meno  -
pausal women who had DEXA scans and coronary
artery calcium scores measured, the latter were 
42 for women with a normal BMD, 182 for women
with osteopenia, and 222 for women with osteo  -
porosis, suggesting that women with a low BMD 
are at higher risk of coronary atherosclerosis [12]. 
Using the Framingham coronary heart disease
risk prediction algorithm in 1804 women aged 
50 to 74 years, women with a 10% to 19% coronary
heart disease risk within 10 years were significantly
45% more likely to have a low BMD than women
with a less than 10% chance of developing coronary
heart disease within 10 years [13]. Women with
a 20% or higher coronary heart disease risk within
10 years were significantly 73% more likely to have
a low BMD than women with a less than 10%
chance of developing coronary heart disease within
10 years. Similar increases in low BMD risk were
not observed in men [13]. 
Marcovitz et al. showed in 209 patients (89%
women and 11% men), mean age 67 years, that
obstructive coronary artery disease with ≥ 50%
narrowing of at least 1 major coronary artery was
present in 122 of 157 patients (78%) with a low
BMD and in 26 of 52 patients (50%) with a normal
BMD (p < 0.001) [14]. In this study, multivessel
coronary  artery  disease  was  present  in  86  of 
157 patients (55%) with a low BMD and in 13 of 
52 patients (25%) with a normal BMD (p = 0.0002).
The DEXA scans and coronary angiograms were
performed within the same 12-month period. 
Multivariate  step-down  logistic  regression
analysis  showed  that  significant  independent
predictors of obstructive coronary artery disease
were  osteoporosis  (odds  ratio  [OR]  =  5.58),
hypertension (OR = 3.92), family history of pre  ma  -
ture coronary artery disease (OR = 2.99), and
fasting  glucose  level  greater  than  110  mg/dl 
(OR = 3.28) [14]. Osteoporosis and osteopenia were
also significantly associated with any degree of
vessel narrowing [14].
Coronary angiography was performed because
of chest pain in 198 patients (76% women and 24%
men), mean age 66 years, who had DEXA scans of
the  spine  and  left  hip  because  of  suspected
osteoporosis or osteopenia within 6 months of
coronary  angiography  [15].  Osteoporosis  was
diagnosed when the T score was < –2.5 standard
deviations below peak bone mass and osteopenia
was diagnosed when the T score was –1.0 to –2.5
standard deviations below peak bone mass [16].
Normal BMD was diagnosed if the T score was 
> –1.0 standard deviations below peak bone mass
[16].  Obstructive  coronary  artery  disease  was
diagnosed if there was > 50% diameter narrowing
of at least 1 major coronary artery.
Of 198 patients, 53 (27%) had osteoporosis, 
79 (40%) had osteopenia, and 66 (33%) had normal
BMD.  The  prevalence  of  gender,  mean  age, 
prior  myocardial  infarction,  current  smoking,
hypertension,  diabetes  mellitus,  hypercholes  -
terolemia, and body mass index ≥ 30 kg/m2 were
not significantly different between patients with
osteoporosis,  osteopenia,  and  normal  BMD.
Obstructive coronary artery disease with > 50%
narrowing of at least 1 major coronary artery 
was  present  in  40  of  53  patients  (76%)  with
osteoporosis, in 54 of 79 patients (68%) withArch Med Sci 1, February / 2011 23
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osteopenia, and in 31 of 66 patients (47%) with
normal BMD (p < 0.005 comparing osteoporosis
with normal BMD and p < 0. 01 comparing osteo  -
penia with normal BMD) [15]. 
The prevalence of obstructive coronary artery
disease was significantly higher in women with
osteoporosis (74%) or osteopenia (66%) than in
women with normal BMD (45%) [15]. The pre  -
valence of obstructive coronary artery disease was
80% in men with osteoporosis, 75% in men with
osteopenia, and 53% in men with normal BMD [15].
These differences were not significantly different
because of the small number of men included in
the study. 
These  data  confirmed  the  association  of
obstructive coronary artery disease with osteo  -
porosis and osteopenia reported by Marcovitz et al.
[14]. A retrospective analysis of 47 men, mean age
65  years,  who  had  DEXA  scans  and  coronary
angiography showed that low BMD was an inde  -
pendent predictor of obstructive coronary artery
disease with an odds ratio of 5.4 (95% CI, 1.66 to
17.49) [17]. The mechanism of this association
remains to be investigated.
Osteopontin
Osteopontin is a noncollagenous bone matrix
protein produced by osteocytes, osteoblasts, and
osteoclasts that can interact with the cell surface
receptor CD 44 [18, 19]. Osteopontin is associated
with the presence and extent of coronary artery
disease [20]. In 178 patients undergoing coronary
angiography, mean age 65 years, plasma osteo  -
pontin levels were significantly associated with
coronary artery disease, independent of other risk
factors  [20].  Coronary  artery  calcification  was
present  in  86  of  178  patients  (48%).  Plasma
osteopontin levels were higher in patients with
coronary  artery  calcification  than  in  patients
without coronary artery calcification (p < 0.01) and
correlated with the number of calcified segments
(p < 0.001), but were not independently associated
with coronary artery calcification [20]. 
Production of osteopontin by circulating endo  -
thelial progenitor cells at sites of tissue injury 
may modulate proliferation, migration, and accu  -
mulation  of  endothelial  and  vascular  smooth
muscle cells, promoting vascular repair but ini  -
tiating vascular calcification [19, 21, 22]. The same
pro  inflammatory factors involved in the patho  -
genesis of osteoporosis may lead to expression of
an osteogenic phenotype by endothelial lineage
cells, providing a potential mechanism for the
association between osteoporosis and coronary
artery disease [19].
Observational data support the association of
osteopontin with atherosclerotic and valvular heart
disease [23]. An increased osteoprotegerin level may
be an indicator of a proinflammatory milieu that
promotes atherosclerosis [24].
Exercise stress testing
Exercise capacity measured by exercise stress
testing  is  a predictor  of  coronary  mortality
independent of traditional risk factors for coronary
artery disease [25-27]. Showing an association
between BMD and exercise capacity could help
explain the association between BMD and coronary
artery disease [28]. Therefore, From et al. studied
a cohort of patients who had undergone both
exercise echocardiography and DEXA scans to
determine whether patients with low BMD had
lower exercise capacities and were more likely to
have exercise-induced ischemic changes during
exercise  echocardiography  than  patients  with
normal BMD [28]. 
Of 1142 patients, mean age 64 years, included
in this study, 1001 (88%) were women and 141 (12%)
were men [24]. Of the 1142 patients, 126 (11%) had
osteoporosis, 517 (45%) had osteopenia, and 499
(44%) had normal BMD. Reasons for stopping the
exercise echocardiographic stress test were fatigue
in 761 patients (67%), dyspnea in 273 patients
(24%), hypertension in 66 patients (6%), leg distress
in 46 patients (4%), angina pectoris in 15 patients
(1%), completion of protocol in 18 patients (2%),
and reduction of blood pressure in 10 patients (1%).
The treadmill exercise duration was 7.3 min in
patients with a low BMD versus 8.1 min in patients
with a normal BMD (p < 0.001) [28]. Myocardial
ischemia  developed  during  exercise  echocar  -
diography in 21% of patients with low BMD ver  -
sus  14.7%  of  patients  with  normal  BMD 
(p = 0.007). Patients with normal BMD had lower
wall  motion  score  indexes  during  exercise
echocardiography than patients with low BMD 
(p < 0.001 by Wilcoxon rank sum test).
For  every  1-unit  reduction  in  femoral  neck
T score, a 0.23 min significant reduction in treadmill
exercise duration was found after values were
adjusted for age and other patient cha  racteristics.
For every 1-unit reduction in femoral neck T score,
there  was  a significant  22%  increased  risk  of
myocardial ischemia after values were adjusted for
age and other patient characteristics. Overall after
adjustments, patients with a low BMD who were
referred  for  exercise  echocardiographic  stress
testing, had a 43% significantly greater risk of
myocardial ischemia, than did patients with normal
BMD [28]. 
This study was the first study to demonstrate
that low BMD is associated with exercise-induced
myocardial ischemia and with reduced exercise
capacity [28]. From et al. stated that the association
between low BMD and reduced exercise capacity
suggests that reduced physical activity may in part24 Arch Med Sci 1, February / 2011
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explain the relationship between low BMD and
myocardial ischemia [28]. These findings support
the studies that have linked increased mortality and
higher bone turnover to reduced physical activity
[29, 30]. From et al. suggested that reduced physical
activity contributes to both low BMD and coronary
artery  disease  through  the  development  of
atherosclerotic  vascular disease  [28].  Reduced
exercise capacity and reduced physical activity are
well  established  predictors  of  coronary  artery
disease and mortality [25-27]. 
These findings are strengthened by research
findings demonstrating that various proteins known
to regulate bone formation and bone resorption,
including osteoprotegerin, matrix Gla protein, bone
morphogenetic  protein  and  osteopontin,  are
present in calcified atherosclerotic lesions [31]. 
DEXA scans of the spine and left hip were
obtained prior to stress testing for myocardial
ischemia in 629 women (82%) and 136 men (18%),
mean age 63 years, with chest pain typical of
ischemia and no prior history of coronary artery
disease [32]. No patients with BMD measurements
were excluded from this study. Of the 765 patients,
342 (45%) had an adenosine sestamibi or dipy  -
ridamole stress test, 336 (44%) had a treadmill
sestamibi stress test, 80 (10%) had a treadmill
stress test, and 7 (1%) had an exercise stress echo  -
cardiogram. A treadmill stress test was considered
positive if ST-segment depression developed at least
1.0 mm below the resting level, with the ST segment
extending horizontally for at least 80 msec after the
J point or with downsloping of the ST-segment. In
the presence of resting ST-segment depression, 
an increase of at least 2.0 mm below the resting
level was required [33]. Stress tests were analyzed
for the presence of myocardial ischemia without
knowledge whether the patient had osteoporosis,
osteopenia, or normal BMD.
Osteoporosis was diagnosed if the T score was
< –2.5 standard deviations below peak bone mass
[16]. Osteopenia was diagnosed if the T score was
–1.0 to –2.5 standard deviations below peak bone
mass  [16].  Normal  BMD  was  diagnosed  if  the
T score was > –1.0 standard deviations below peak
bone mass [16]. 
Of the 765 patients, 254 (33%) had osteoporosis,
260 (34%) had osteopenia, and 251 (33%) had
normal BMD [32]. The mean age and prevalence 
of gender, hypertension, hypercholesterolemia,
diabetes mellitus, current smoking, body mass
index  ≥ 30  kg/m2,  and  estimated  glomerular
filtration rate < 60 ml/min/1.73 m2 were not sig  -
nificantly different between patients with osteo  -
porosis, osteopenia, and normal BMD. 
Stress  test-induced  myocardial  ischemia
developed  in  95  of  254  patients  (37%)  with
osteoporosis, in 81 of 260 patients (31%) with
osteopenia, and in 62 of 251 patients (25%) with
normal BMD (p = 0.009) (p = 0.002 comparing
osteoporosis with normal BMD; p = 0.007 com  -
paring osteoporosis or osteopenia with normal
BMD) [32]. The increased prevalence of myocardial
ischemia in patients with low BMD was observed
for  both  exercise  and  pharmacological  stress
testing. 
Stepwise logistic regression analysis to identify
significant independent risk factors for stress test-
induced myocardial ischemia were hypertension
(OR = 1.7), diabetes mellitus (OR = 2.3), body mass
index ≥ 30 kg/m2 (OR = 1.6), age (OR = 1.02 per year
increase  in  age),  and  low  BMD.  Patients  with
osteoporosis or osteopenia had a 1.7 times higher
chance of stress test-induced myocardial ischemia
than those with normal BMD after controlling the
confounding  effects  of  hypertension,  diabetes
mellitus, body mass index, and age [32]. These data
confirmed the association between low BMD and
stress test-induced myocardial ischemia reported
by From et al. [28]. 
Tanko et al. found in 2576 women, mean age 
67 years, in the placebo group of the Multiple
Outcomes  of  Raloxifene  Evaluation  (MORE)
randomized study that the risk of cardiovascular
events significantly increased incrementally with
the number and increasing severity of baseline
vertebral  fractures  [34].  After  adjustment  for
potential confounders, women with osteoporosis
had a 3.9 times significantly increased risk for
cardiovascular events compared with women with
low bone mass [34]. These investigators recom  -
mended that treatment of postmenopausal osteo  -
porosis should include consideration of measures
to prevent cardiovascular events.
Aortic valve calcification
An association between low BMD and increased
prevalence of aortic valve calcification [35] and 
of abdominal aortic calcifications [36] has been
observed in older women with low BMD. Skolnick
et  al. also  demonstrated  in  55  patients  with
osteoporosis and aortic stenosis that treatment of
osteoporosis was associated with a significant
reduction  in  progression  of  aortic  stenosis  at 
2.4-year follow-up [37]. These data warrant further
investigation. 
Mechanisms 
As discussed, mechanisms for the association
between low BMD and atherosclerotic vascular
disease and valvular calcification include common
risk  factors  including  smoking,  hypertension,
physical inactivity, dyslipidemia, and menopause.
Increased plasma osteopontin levels and proin-
flammatory factors as discussed also play a role.Arch Med Sci 1, February / 2011 25
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Osteoprotegerin-deficient mice develop early onset
osteoporosis and calcification of the aorta and renal
arteries [38]. An atherogenic high fat diet reduces
bone formation in mice [39]. Use of statins has
been  associated  with  higher  BMD  [40]  and
decreased risk of fractures [41, 42]. Mice lacking the
gene for matrix gla protein have vascular cal  -
cification, osteopenia, and fractures [43]. The ApoE
4 gene is also associated with decreased BMD and
increased risk of fractures [44, 45]. 
In conclusion, on the basis of the available
findings, patients with osteoporosis or osteopenia
should be considered of high cardiovascular risk,
especially when other major cardiovascular risk
factors coexist. Exercise stress testing could be the
diagnostic method of choice to rule out coronary
artery disease in these patients. Patients with
osteoporosis or osteopenia should also be treated
with intensive risk factor modification in addition
to treatment of the osteoporosis or osteopenia.
Further studies are indicated to investigate the
mechanisms by which low BMD is associated 
with coronary artery disease, stress test-induced
myocardial  ischemia,  atherosclerotic  vascular
disease, and aortic valve calcification.
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